Compare CCEL & FRMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | FRMM |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | 76 | N/A |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 49.8M |
| IPO Year | 2022 | 2017 |
| Metric | CCEL | FRMM |
|---|---|---|
| Price | $5.31 | $3.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 11.1K | ★ 126.2K |
| Earning Date | 10-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $25,384,279.00 | $6,547,000.00 |
| Revenue This Year | N/A | $177.58 |
| Revenue Next Year | N/A | $587.83 |
| P/E Ratio | $22.54 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $1.76 |
| 52 Week High | $5.45 | $7.15 |
| Indicator | CCEL | FRMM |
|---|---|---|
| Relative Strength Index (RSI) | 62.09 | 35.93 |
| Support Level | $3.16 | $3.05 |
| Resistance Level | N/A | $5.12 |
| Average True Range (ATR) | 0.41 | 0.34 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 81.34 | 29.10 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.